IntelliSyn was founded by Jeffrey Albert in 2011 to bring together outstanding pharma researchers in the Montreal area following the closure of major sites by AstraZeneca, Boehringer Ingelheim, and Merck Frosst.

Within these companies, our team members worked with scientific CROs from all across the world and came to understand the frequent challenges and frustrations with these CROs. IntelliSyn was formed to bring highly efficient capabilities and experienced personnel to rapidly advance client’s projects on a reliable, secure, and economical basis.